On the other hand, there were fewer IL-10+ monocytes observed for NMOSD and MS under both US (MS, p < 0.05; NMOSD, p < 0.01) and CD40L-stimulated conditions (MS, p < 0.01; NMOSD, p < 0.001) (Fig. 2a). The gene discussed is IL10; the disease is myeloid sarcoma.